Startseite Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Energy substrate metabolism in pyruvate dehydrogenase complex deficiency

  • Maria Halldin Stenlid , Fredrik Ahlsson EMAIL logo , Anders Forslund , Ulrika von Döbeln und Jan Gustafsson
Veröffentlicht/Copyright: 10. Juni 2014

Abstract

Pyruvate dehydrogenase (PDH) deficiency is an inherited disorder of carbohydrate metabolism, resulting in lactic acidosis and neurological dysfunction. In order to provide energy for the brain, a ketogenic diet has been tried. Both the disorder and the ketogenic therapy may influence energy production. The aim of the study was to assess hepatic glucose production, lipolysis and resting energy expenditure (REE) in an infant, given a ketogenic diet due to neonatal onset of the disease. Lipolysis and glucose production were determined for two consecutive time periods by constant-rate infusions of [1,1,2,3,3-2H5]-glycerol and [6,6-2H2]-glucose. The boy had been fasting for 2.5 h at the start of the sampling periods. REE was estimated by indirect calorimetry. Rates of glucose production and lipolysis were increased compared with those of term neonates. REE corresponded to 60% of normal values. Respiratory quotient (RQ) was increased, indicating a predominance of glucose oxidation. Blood lactate was within the normal range. Several mechanisms may underlie the increased rates of glucose production and lipolysis. A ketogenic diet will result in a low insulin secretion and reduced peripheral and hepatic insulin sensitivity, leading to increased production of glucose and decreased peripheral glucose uptake. Surprisingly, RQ was high, indicating active glucose oxidation, which may reflect a residual enzyme activity, sufficient during rest. Considering this, a strict ketogenic diet might not be the optimal choice for patients with PDH deficiency. We propose an individualised diet for this group of patients aiming at the highest glucose intake that each patient will tolerate without elevated lactate levels.


Corresponding author: Fredrik Ahlsson, Department of Women’s and Children’s Health, Uppsala University, SE-751 85 Uppsala, Sweden, E-mail:

Acknowledgments

We are grateful to many people for their assistance in this work: The nurses at the ward for excellent help in the study; Christina Eklund for skilful dietary instructions; Elisabeth Söderberg for expert assistance with the stable isotope analysis; the staff at CMMS, Karolinska University Hospital, Huddinge, Sweden, for skilful laboratory assistance; and Roger Olsson for assistance in the indirect calorimetry and the REE calculations.

References

1. Pithukpakorn M. Disorders of pyruvate metabolism and the tricarboxylic acid cycle. Mol Genet Metab 2005;85:243–6.10.1016/j.ymgme.2005.06.006Suche in Google Scholar

2. McKusick VA. Genetic studies in American inbred populations with particular reference to the Old Order Amish. Isr J Med Sci 1973;9:1276–84.Suche in Google Scholar

3. Wikland KA, Luo ZC, Niklasson A, Karlberg J. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 2002;91:739–54.10.1111/j.1651-2227.2002.tb03322.xSuche in Google Scholar

4. Food and Drug Administration. Guideline on Validation of Limulus Amebocyte Lysate Test as End-Product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products and Medical Devices. Washington, DC: Food and Drug Administration, 1987.Suche in Google Scholar

5. Halldin MU, Brismar K, Tuvemo T, Gustafsson J. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. Clin Endocrinol (Oxf) 2002;57:735–43.10.1046/j.1365-2265.2002.01656.xSuche in Google Scholar

6. Sunehag A, Gustafsson J, Ewald U. Glycerol carbon contributes to hepatic glucose production during the first eight hours in healthy term infants. Acta Paediatr 1996;85:1339–43.10.1111/j.1651-2227.1996.tb13921.xSuche in Google Scholar

7. Halldin MU, Forslund A, von Dobeln U, Eklund C, Gustafsson J. Increased lipolysis in LCHAD deficiency. J Inherit Metab Dis 2007;30:39–46.10.1007/s10545-006-0296-xSuche in Google Scholar

8. Ahlsson FS, Diderholm B, Ewald U, Gustafsson J. Lipolysis and insulin sensitivity at birth in infants who are large for gestational age. Pediatrics 2007;120:958–65.10.1542/peds.2007-0165Suche in Google Scholar

9. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949;109:1–9.10.1113/jphysiol.1949.sp004363Suche in Google Scholar

10. Persson B. Determination of plasma acetoacetate and D-beta-hydroxybutyrate in new-born infants by an enzymatic fluorometric micro-method. Scand J Clin Lab Invest 1970;25:9–18.10.3109/00365517009046184Suche in Google Scholar

11. Lundin A, Arner P, Hellmer J. A new linear plot for standard curves in kinetic substrate assays extended above the Michaelis-Menten constant: application to a luminometric assay of glycerol. Anal Biochem 1989;177:125–31.10.1016/0003-2697(89)90026-2Suche in Google Scholar

12. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39:5–41.Suche in Google Scholar

13. Bier DM, Leake RD, Haymond MW, Arnold KJ, Gruenke LD, et al. Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977;26:1016–23.10.2337/diab.26.11.1016Suche in Google Scholar PubMed

14. Bougneres PF, Karl IE, Hillman LS, Bier DM. Lipid transport in the human newborn. Palmitate and glycerol turnover and the contribution of glycerol to neonatal hepatic glucose output. J Clin Invest 1982;70:262–70.Suche in Google Scholar

15. Patel D, Kalhan S. Glycerol metabolism and triglyceride-fatty acid cycling in the human newborn: effect of maternal diabetes and intrauterine growth retardation. Pediatr Res 1992;31:52–8.10.1203/00006450-199201000-00010Suche in Google Scholar PubMed

16. Siesjo BK. Hypoglycemia, brain metabolism, and brain damage. Diabetes Metab Rev 1988;4:113–44.10.1002/dmr.5610040203Suche in Google Scholar PubMed

17. Clarke D, Sokoloff L. Circulation and energy metabolism of the brain: substrates of cerebral metabolism. In: Siegel GJ, Agranoff B, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry molecular, cellular and medical aspects, 6th ed. Philadelphia: Lippincott, Williams & Wilkins, 1999:637–70.Suche in Google Scholar

18. Kruszynska Y. Normal metabolism: the physiology of fuel homeostasis. In: Pickup J, Williams G, editors. Textbook of diabetes, 2nd ed. London, England: Blackwell Sciences Ltd., 1997:11.1–.37.Suche in Google Scholar

19. Boden G. Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care 2002;5:545–9.10.1097/00075197-200209000-00014Suche in Google Scholar PubMed

20. van Kempen AA, Ackermans MT, Endert E, Kok JH, Sauerwein HP. Glucose production in response to glucagon is comparable in preterm AGA and SGA infants. Clin Nutr 2005;24:727–36.10.1016/j.clnu.2005.02.004Suche in Google Scholar PubMed

21. Sunehag AL, Treuth MS, Toffolo G, Butte NF, Cobelli C, et al. Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res 2001;50:115–23.10.1203/00006450-200107000-00021Suche in Google Scholar PubMed

22. Stumvoll M, Jacob S. Multiple sites of insulin resistance: muscle, liver and adipose tissue. Exp Clin Endocrinol Diabetes 1999;107:107–10.10.1055/s-0029-1212083Suche in Google Scholar PubMed

23. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, et al. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 1999;276:E1055–66.10.1152/ajpendo.1999.276.6.E1055Suche in Google Scholar PubMed

24. McClave SA, Lowen CC, Kleber MJ, McConnell JW, Jung LY, et al. Clinical use of the respiratory quotient obtained from indirect calorimetry. J Parenter Enteral Nutr 2003;27:21–6.10.1177/014860710302700121Suche in Google Scholar PubMed

25. Sharma N, Okere IC, Brunengraber DZ, McElfresh TA, King KL, et al. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation. J Physiol 2005;562:593–603.10.1113/jphysiol.2004.075713Suche in Google Scholar PubMed PubMed Central

Received: 2013-10-28
Accepted: 2014-4-23
Published Online: 2014-6-10
Published in Print: 2014-11-1

©2014 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Cushing syndrome
  3. Fundamental principles of clinical and biochemical evaluation underlie the diagnosis and therapy of Cushing’s syndrome
  4. Cushing syndrome secondary to CRH-producing Wilms tumor in a 6 year old
  5. Cushing’s disease presenting as cholestatic hepatitis
  6. How early can one diagnose Cushing’s disease? An early diagnosis in a case of prepubertal Cushing’s disease
  7. Review article
  8. Subclinical hypothyroidism in childhood and adolescense
  9. Original articles
  10. Energy substrate metabolism in pyruvate dehydrogenase complex deficiency
  11. Chromosome 6q24 transient neonatal diabetes mellitus and protein sensitive hyperinsulinaemic hypoglycaemia
  12. Measures of pituitary gland and stalk: from neonate to adolescence
  13. Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?
  14. Pseudohypoparathyroidism vs. tricho-rhino-phalangeal syndrome: patient reclassification
  15. Association of serum 25-hydroxyvitamin D with race/ethnicity and constitutive skin color in urban schoolchildren
  16. A nonsense thyrotropin receptor gene mutation (R609X) is associated with congenital hypothyroidism and heart defects
  17. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents
  18. Clinical characteristics and chromosome 11p15 imprinting analysis of Silver-Russell syndrome – a Chinese experience
  19. Change in reference body mass index percentiles and deviation in overweight and obesity over 3 years in Turkish children and adolescents
  20. Long-term outcomes of pediatric Graves’ disease
  21. Accessibility of the reference center as a protective factor against ketoacidosis at the onset of diabetes in children
  22. Vitamin D, parathormone, and insulin resistance in children born large for gestational age
  23. Prevalence of vitamin D deficiency in apparently healthy children in north India
  24. Prevalence of autoantibodies in type 1 diabetes patients and its association with the clinical presentation – UAE Eastern Region experience
  25. Clinical and molecular studies related to bone metabolism in patients with congenital adrenal hyperplasia
  26. Islet neogenesis-associated protein-related pentadecapeptide improves the function of allograft after islets transplantation
  27. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents
  28. Early infant feeding practice and childhood obesity: the relation of breast-feeding and timing of solid food introduction with childhood obesity
  29. Late onset X-linked adrenal hypoplasia congenita with hypogonadotropic hypgonadism due to a novel 4-bp deletion in exon 2 of NR0B1
  30. The correlation between GnRH stimulation testing and obstetric ultrasonographic parameters in precocious puberty
  31. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature
  32. Concentrations of tumour necrosis factor-α and its soluble receptors in the serum of teenagers with atherosclerosis risk factors: obesity or obesity combined with hypertension
  33. Are HDL levels lower in children with type 1 diabetes and concurrent celiac disease compared with children with type 1 diabetes only?
  34. Patient reports
  35. Hereditary vitamin D rickets: a case series in a family
  36. Two heterozygous mutations of the AMH gene in a Japanese patient with persistent Müllerian duct syndrome
  37. Two case reports of severe pediatric hyperosmolar hyperglycemia and diabetic ketoacidosis accompanied with rhabdomyolysis and acute renal failure
  38. Acquired hypothyroidism due to iodine deficiency in an American child
  39. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome
  40. Amylase/creatinine clearance ratio in diabetic ketoacidosis: a case report
  41. Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature
  42. Congenital hyperinsulinism in a newborn with a novel homozygous mutation (p.Q392H) in the ABCC8 gene
  43. Short communications
  44. Polyglandular autoimmune syndrome type I – a novel AIRE mutation in a North American patient
  45. Post-hemorrhagic hydrocephalus and diabetes insipidus in preterm infants
  46. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease
  47. Letter to the Editor
  48. And what about septin 9 (SEPT9) as a binding partner of survivin in heart regeneration?
Heruntergeladen am 20.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0423/html
Button zum nach oben scrollen